<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T17:51:56Z</responseDate>
  <request identifier="oai:figshare.com:article/34040250" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34040250</identifier>
        <datestamp>2026-10-01T06:05:05Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_24</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Structural Modifications
Redirect Phenylpyrazole Ectoparasiticides
from the Ion Channel Pore to an Allosteric Site on GABA Receptors</dc:title>
          <dc:creator>Tianhao Zhou (6095903)</dc:creator>
          <dc:creator>Zihan Cheng (5713415)</dc:creator>
          <dc:creator>Honglei Xie (3162414)</dc:creator>
          <dc:creator>Ailing Liu (119500)</dc:creator>
          <dc:creator>Shoujun Li (572627)</dc:creator>
          <dc:creator>Xiaomu Qiao (656142)</dc:creator>
          <dc:creator>Jia Huang (42138)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Evolutionary Biology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>targeted insecticide design</dc:subject>
          <dc:subject>pharmacological assays showed</dc:subject>
          <dc:subject>molecular docking supported</dc:subject>
          <dc:subject>arthropod gaba receptors</dc:subject>
          <dc:subject>traditional pore blockers</dc:subject>
          <dc:subject>ion channel pore</dc:subject>
          <dc:subject>molecular mechanism</dc:subject>
          <dc:subject>gaba receptor</dc:subject>
          <dc:subject>central pore</dc:subject>
          <dc:subject>structural modification</dc:subject>
          <dc:subject>site engagement</dc:subject>
          <dc:subject>results demonstrate</dc:subject>
          <dc:subject>redirect target</dc:subject>
          <dc:subject>phenylpyrazole scaffold</dc:subject>
          <dc:subject>noncompetitive antagonists</dc:subject>
          <dc:subject>nicofluprole sensitivity</dc:subject>
          <dc:subject>nicofluprole binds</dc:subject>
          <dc:subject>mediated mutagenesis</dc:subject>
          <dc:subject>little effect</dc:subject>
          <dc:subject>g335 mutations</dc:subject>
          <dc:subject>expanding strategies</dc:subject>
          <dc:subject>allosteric site</dc:subject>
          <dc:subject>allosteric modulation</dc:subject>
          <dc:subject>a301 substitutions</dc:subject>
          <dc:description>Phenylpyrazole ectoparasiticides, exemplified by fipronil,
act
as noncompetitive antagonists of arthropod GABA receptors by blocking
the ion channel pore. Here, we investigated the molecular mechanism
of the newer phenylpyrazole nicofluprole using Drosophila
melanogaster. CRISPR/Cas9-mediated mutagenesis and
pharmacological assays showed that A301 substitutions in the pore-forming
TM2 helix conferred strong resistance to fipronil but had little effect
on nicofluprole sensitivity. In contrast, G335 mutations in TM3 markedly
reduced nicofluprole activity. Molecular docking supported these findings,
indicating that nicofluprole binds at the transmembrane subunit interface
rather than within the central pore, consistent with allosteric modulation.
These results demonstrate that structural modification of the phenylpyrazole
scaffold can redirect target-site engagement from the pore to an allosteric
site, explaining the lack of cross-resistance with traditional pore
blockers and expanding strategies for GABA receptor-targeted insecticide
design.</dc:description>
          <dc:date>2026-10-01T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acs.jafc.6c09630.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Structural_Modifications_Redirect_Phenylpyrazole_Ectoparasiticides_from_the_Ion_Channel_Pore_to_an_Allosteric_Site_on_GABA_Receptors/34040250</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
